327 related articles for article (PubMed ID: 21730835)
21. Novel targets for anticoagulants lacking bleeding risk.
Bickmann JK; Baglin T; Meijers JCM; Renné T
Curr Opin Hematol; 2017 Sep; 24(5):419-426. PubMed ID: 28731874
[TBL] [Abstract][Full Text] [Related]
22. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
Müller F; Renné T
Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
[TBL] [Abstract][Full Text] [Related]
23. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants.
Weitz JI; Fredenburgh JC
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):304-310. PubMed ID: 29269514
[TBL] [Abstract][Full Text] [Related]
24. The many faces of the contact pathway and their role in thrombosis.
Woodruff RS; Sullenger B; Becker RC
J Thromb Thrombolysis; 2011 Jul; 32(1):9-20. PubMed ID: 21404067
[TBL] [Abstract][Full Text] [Related]
25. Novel roles for factor XII-driven plasma contact activation system.
Müller F; Renné T
Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
[TBL] [Abstract][Full Text] [Related]
26. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
27. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
Walsh PN; Griffin JH
Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
[No Abstract] [Full Text] [Related]
28. New agents for thromboprotection. A role for factor XII and XIIa inhibition.
Labberton L; Kenne E; Renné T
Hamostaseologie; 2015; 35(4):338-50. PubMed ID: 25609114
[TBL] [Abstract][Full Text] [Related]
29. The Safety and Efficacy of Novel Agents Targeting Factors XI and XII in Early Phase Human Trials.
DeLoughery EP; Olson SR; Puy C; McCarty OJT; Shatzel JJ
Semin Thromb Hemost; 2019 Jul; 45(5):502-508. PubMed ID: 31216587
[TBL] [Abstract][Full Text] [Related]
30. Factor XI Inhibition to Uncouple Thrombosis From Hemostasis: JACC Review Topic of the Week.
Hsu C; Hutt E; Bloomfield DM; Gailani D; Weitz JI
J Am Coll Cardiol; 2021 Aug; 78(6):625-631. PubMed ID: 34353538
[TBL] [Abstract][Full Text] [Related]
31. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
32. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
Stavrou E; Schmaier AH
Thromb Res; 2010 Mar; 125(3):210-5. PubMed ID: 20022081
[TBL] [Abstract][Full Text] [Related]
33. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
Renné T; Nieswandt B; Gailani D
Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
[TBL] [Abstract][Full Text] [Related]
34. Factor XI deficiency in animal models.
Renné T; Oschatz C; Seifert S; Müller F; Antovic J; Karlman M; Benz PM
J Thromb Haemost; 2009 Jul; 7 Suppl 1():79-83. PubMed ID: 19630774
[TBL] [Abstract][Full Text] [Related]
35. Coagulation factors XI and XII as possible targets for anticoagulant therapy.
Kluge KE; Seljeflot I; Arnesen H; Jensen T; Halvorsen S; Helseth R
Thromb Res; 2022 Jun; 214():53-62. PubMed ID: 35490644
[TBL] [Abstract][Full Text] [Related]
36. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
Mandle RJ; Kaplan AP
Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
[TBL] [Abstract][Full Text] [Related]
37. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
Wiggins RC; Cochrane CG; Griffin JH
Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
[No Abstract] [Full Text] [Related]
38. [New anticoagulants in 2024: Development of factor XI and XIa inhibitors].
Bentounes NK; Melicine S; Martin AC; Smadja DM; Gendron N
Ann Biol Clin (Paris); 2024 Apr; 82(1):9-23. PubMed ID: 38638015
[TBL] [Abstract][Full Text] [Related]
39. Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow.
Keeling NM; Wallisch M; Johnson J; Le HH; Vu HH; Jordan KR; Puy C; Tucker EI; Nguyen KP; McCarty OJT; Aslan JE; Hinds MT; Anderson DEJ
J Thromb Haemost; 2024 May; 22(5):1433-1446. PubMed ID: 38331196
[TBL] [Abstract][Full Text] [Related]
40. Factor XI as a Target for New Anticoagulants.
Fredenburgh JC; Weitz JI
Hamostaseologie; 2021 Apr; 41(2):104-110. PubMed ID: 33860518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
